- Home
- AUTL vs ETJ Comparison
AUTL vs ETJ Comparison
Compare AUTL & ETJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- ETJ
- Stock Information
- Founded
- AUTL 2014
- ETJ 2007
- Country
- AUTL United Kingdom
- ETJ United States
- Employees
- AUTL N/A
- ETJ N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- ETJ Finance Companies
- Sector
- AUTL Health Care
- ETJ Finance
- Exchange
- AUTL Nasdaq
- ETJ Nasdaq
- Market Cap
- AUTL 625.4M
- ETJ 578.8M
- IPO Year
- AUTL 2018
- ETJ N/A
- Fundamental
- Price
- AUTL $2.47
- ETJ $8.98
- Analyst Decision
- AUTL Strong Buy
- ETJ
- Analyst Count
- AUTL 5
- ETJ 0
- Target Price
- AUTL $9.32
- ETJ N/A
- AVG Volume (30 Days)
- AUTL 1.8M
- ETJ 175.6K
- Earning Date
- AUTL 08-07-2025
- ETJ 01-01-0001
- Dividend Yield
- AUTL N/A
- ETJ 8.30%
- EPS Growth
- AUTL N/A
- ETJ N/A
- EPS
- AUTL N/A
- ETJ N/A
- Revenue
- AUTL $9,011,000.00
- ETJ N/A
- Revenue This Year
- AUTL $461.76
- ETJ N/A
- Revenue Next Year
- AUTL $112.66
- ETJ N/A
- P/E Ratio
- AUTL N/A
- ETJ N/A
- Revenue Growth
- AUTL N/A
- ETJ N/A
- 52 Week Low
- AUTL $1.11
- ETJ $7.20
- 52 Week High
- AUTL $5.00
- ETJ $8.47
- Technical
- Relative Strength Index (RSI)
- AUTL 69.22
- ETJ 56.41
- Support Level
- AUTL $2.24
- ETJ $8.60
- Resistance Level
- AUTL $2.53
- ETJ $9.09
- Average True Range (ATR)
- AUTL 0.13
- ETJ 0.08
- MACD
- AUTL -0.00
- ETJ 0.00
- Stochastic Oscillator
- AUTL 88.55
- ETJ 77.31
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Risk-Managed Diversified Equity Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The group invests in various sectors such as financials, healthcare, consumer discretionary, consumer staples, industrials, energy, utilities, telecommunication services, and materials. Under normal market conditions, the Fund's investment program consists of majorly owning a diversified portfolio of common stocks and employing a variety of options strategies.